Sonablate 450

High Intensity Ultrasound System For Prostate Tissue Ablation

SonaCare Medical, LLC.

The following data is part of a De Novo classification by Sonacare Medical, Llc. with the FDA for Sonablate 450.

Pre-market Notification Details

DeNovo IDDEN150011
Device Name:Sonablate 450
ClassificationHigh Intensity Ultrasound System For Prostate Tissue Ablation
Applicant SonaCare Medical, LLC. 801 E. Morehead St suite 201 Charlotte,  NC  28202
ContactDawn Byrd Burleson
Product CodePLP  
CFR Regulation Number876.4340 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationDevice Classification Under Section 513(f)(2)(De Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin
Review Advisory BoardGastroenterology/Urology
Classification AdvisoryGastroenterology/Urology
TypeDirect
Date Received2015-03-23
Decision Date2015-10-09
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00868108000274 DEN150011 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.